Cargando…

Understanding reasons and factors for participation and non-participation to a medication adherence program for patients with diabetic kidney disease in Switzerland: a mixed methods study

BACKGROUND: An interprofessional medication adherence intervention led by pharmacists, combining motivational interviews and feedback with electronic monitor (EM) drug assessment, was offered to all consecutive patients with diabetic kidney disease (DKD) (estimated glomerular filtration rate < 60...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bandiera, Carole, Lam, Liliane, Locatelli, Isabella, Dotta-Celio, Jennifer, Duarte, Dina, Wuerzner, Gregoire, Pruijm, Menno, Zanchi, Anne, Schneider, Marie P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516833/ https://www.ncbi.nlm.nih.gov/pubmed/36167584 http://dx.doi.org/10.1186/s13098-022-00898-7

Ejemplares similares

Interprofessional Medication Adherence Program for Patients With Diabetic Kidney Disease: Protocol for a Randomized Controlled and Qualitative Study (PANDIA-IRIS)
por: Bandiera, Carole, et al.
Publicado: (2021)

Medication Adherence Evaluated Through Electronic Monitors During the 2020 COVID-19 Pandemic Lockdown in Switzerland: A Longitudinal Analysis
por: Bandiera, Carole, et al.
Publicado: (2022)

Contrast-Enhanced Ultrasonography Enables the Detection of a Cold Pressor Test-Induced Increase in Renal Microcirculation in Healthy Participants
por: Hendriks-Balk, Mariëlle C., et al.
Publicado: (2022)

Clinical Benefits of an Adherence Monitoring Program in the Management of Secondary Hyperparathyroidism with Cinacalcet: Results of a Prospective Randomized Controlled Study
por: Forni Ogna, Valentina, et al.
Publicado: (2013)

Blood pressure and vascular determinants of glomerular filtration rate decline in diabetic kidney disease
por: Truscello, Luca, et al.
Publicado: (2023)

Long-term use and tolerability of irbesartan for control of hypertension
por: Forni, Valentina, et al.
Publicado: (2011)

Twenty-Four Hour Blood Pressure Response to Empagliflozin and Its Determinants in Normotensive Non-diabetic Subjects
por: Zanchi, Anne, et al.
Publicado: (2022)

May Measurement Month 2017–2019: results from Switzerland( )
por: Damianaki, Aikaterini, et al.
Publicado: (2022)

Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study
por: Bandiera, Carole, et al.
Publicado: (2023)

Determinants of Renal Micro-Perfusion as Assessed with Contrast-Enhanced Ultrasound in Healthy Males and Females
por: Ulpiano Trillig, Antonio, et al.
Publicado: (2023)

Hypertension and Drug Adherence in the Elderly
por: Burnier, Michel, et al.
Publicado: (2020)

Mortality in Switzerland in 2021
por: Locatelli, Isabella, et al.
Publicado: (2022)

Patient adherence and the choice of antihypertensive drugs: focus on lercanidipine
por: Pruijm, Menno T, et al.
Publicado: (2008)

Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data
por: Bandiera, Carole, et al.
Publicado: (2021)

Effects of the SGLT-2 Inhibitor Empagliflozin on Renal Tissue Oxygenation in Non-Diabetic Subjects: A Randomized, Double-Blind, Placebo-Controlled Study Protocol
por: Muller, Marie-Eve, et al.
Publicado: (2018)

Interdisciplinary Medication Adherence Program: The Example of a University Community Pharmacy in Switzerland
por: Lelubre, Mélanie, et al.
Publicado: (2015)

General practitioners’ willingness to participate in research: A survey in central Switzerland
por: Tawo, Serlha, et al.
Publicado: (2019)

Predictors for participation in DNA self-sampling of childhood cancer survivors in Switzerland
por: Waespe, Nicolas, et al.
Publicado: (2021)

A first analysis of excess mortality in Switzerland in 2020
por: Locatelli, Isabella, et al.
Publicado: (2021)

Federal Food Assistance Program Participation during the COVID-19 Pandemic: Participant Perspectives and Reasons for Discontinuing
por: Melnick, Emily M., et al.
Publicado: (2022)

Perceptions of Participants on Trial Participation and Adherence to Tai Chi: A Qualitative Study
por: Yang, Guoyan, et al.
Publicado: (2022)

Two complementary approaches to estimate an excess of mortality: The case of Switzerland 2022
por: Locatelli, Isabella, et al.
Publicado: (2023)

Reasons for late presentation to HIV care in Switzerland
por: Hachfeld, Anna, et al.
Publicado: (2015)

What Motivates Participants to Adhere to Green Exercise?
por: Fraser, Matthew, et al.
Publicado: (2019)

Examining Participant Adherence with Wearables in an In-the-Wild Setting
por: Nolasco, Hannah R., et al.
Publicado: (2023)

Participation and democratic theory /
por: Pateman, Carole
Publicado: (1970)

Prior medication adherence of participants and non participants of a randomized controlled trial to improve patient adherence in cardiovascular risk management
por: Sieben, A., et al.
Publicado: (2019)

Reasons for participation and non-participation in a diabetes prevention trial among women with prior gestational diabetes mellitus (GDM)
por: Infanti, Jennifer J, et al.
Publicado: (2014)

Who Participates in Seasonal Influenza Vaccination? Past Behavior Moderates the Prediction of Adherence
por: Ernsting, Anna, et al.
Publicado: (2011)

Mobilizing agencies for incidence surveys on child maltreatment: successful participation in Switzerland and lessons learned
por: Jud, Andreas, et al.
Publicado: (2018)

To strike or not to strike? an investigation of the determinants of strike participation at the Fridays for Future climate strikes in Switzerland
por: Cologna, Viktoria, et al.
Publicado: (2021)

Facilitators and barriers of women's participation in HIV clinical research in Switzerland: A qualitative study
por: Courvoisier, Nelly, et al.
Publicado: (2022)

Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy
por: Jenkins, V, et al.
Publicado: (2000)

Reasons for participating in randomised controlled trials: conditional altruism and considerations for self
por: McCann, Sharon K, et al.
Publicado: (2010)

Sex-differences in reasons for non-participation at recruitment: Geelong Osteoporosis Study
por: Markanday, Shikha, et al.
Publicado: (2013)

Reasons for non-participation in malformation scans in Denmark: a cohort study
por: Hjort-Pedersen, Karina, et al.
Publicado: (2018)

Reasons for Non-Participation in an Actigraphy Study in an Alzheimer’s Disease Center Registry
por: Laffer, Alex, et al.
Publicado: (2020)

‘Sick and tired’: Patients reported reasons for not participating in clinical psychiatric research
por: Bixo, Liv, et al.
Publicado: (2019)

Ready to participate? Using qualitative data to typify older adults’ reasons for (non-) participation in a physical activity promotion intervention
por: Wichmann, Frauke, et al.
Publicado: (2019)

High Performance on a Pragmatic Task May Not Be the Result of Successful Reasoning: On the Importance of Eliciting Participants’ Reasoning Strategies
por: Mayn, Alexandra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u0cm94vtm1nsp52fsf9prur7hu